Clinical Trials Browser

Interventional × inebilizumab × 30 days × Clear all

NCT06987539 2026-03-16

THYME

Phase 2 Recruiting

Myasthenia Gravis

NCT04524273 2026-03-10

MINT

Phase 3 Active not recruiting

238 enrolled 36 charts

Myasthenia Gravis